
 
Sep 19, 2008

PR No.:  
179/2008 


PRESS RELEASE
PR No.179/2008


Grant of exemption to Mahaganpati Investment Private Limited for the proposed acquisition of shares in M/s. Parenteral Drugs (India) Ltd.


Dr. T.C. Nair, Whole Time Member, SEBI, has passed an order dated  September 18, 2008, granting exemption to Mahaganpati Investment Private Limited (acquirers) from  applicability of Regulation 11(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 1997, in respect of their proposed acquisition of 24,00,000 warrants convertible into equivalent equity shares of M/s. Parenteral Drugs (India) Ltd. This exemption is subject to the certain conditions specified in the Order.
The application seeking exemption was forwarded by *SEBI to the Takeover Panel. The Panel did not recommend grant of exemption to the acquirers in respect of the proposed acquisition of equity shares pursuant to conversion of warrants allotted to the acquirer.
The full text of the above order is available on the website: www.sebi.gov.in
Mumbai
September 19, 2008

